SOLU-MEDROL

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Tunisia.

Active ingredients

The drug SOLU-MEDROL contains one active pharmaceutical ingredient (API):

1	Methylprednisolone UNII LEC9GKY20K - METHYLPREDNISOLONE SODIUM SUCCINATE
	Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system.
	Read more about Methylprednisolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SOLU-MEDROL Powder for injection	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB04	Methylprednisolone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11739W, 5264C
BR	Câmara de Regulação do Mercado de Medicamentos	522718010072117, 522718010072217, 522718010072317, 522718010072417
CA	Health Products and Food Branch	00030678, 00036137, 02367947, 02367955, 02367963, 02367971
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28620-10-08, 28622-10-08
EE	Ravimiamet	1007378, 1009112, 1009134, 1009156, 1009178
FI	Lääkealan turvallisuus- ja kehittämiskeskus	119953, 390116, 475703, 498818
FR	Base de données publique des médicaments	60626197, 69424357, 69618515, 69774343
HK	Department of Health Drug Office	00456, 00466
HR	Agencija za lijekove i medicinske proizvode	HR-H-208583910, HR-H-495302524, HR-H-649886548, HR-H-914993276
IL	מִשְׂרַד הַבְּרִיאוּת	138, 139, 8220, 8221
JP	医薬品医療機器総合機構	2456400D1067, 2456400D2098, 2456400D3094, 2456400D4074
LT	Valstybinė vaistų kontrolės tarnyba	1004534, 1004535, 1004536, 1004537
MT	Medicines Authority	AA565/52201, AA565/52202
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	74986
NL	Z-Index G-Standaard, PRK	20370, 26050, 26069, 388
NZ	Medicines and Medical Devices Safety Authority	1128, 1137, 1138, 1139, 8783
PL	Rejestru Produktów Leczniczych	100061820, 100061837, 100061843, 100061850, 100247097, 100326336
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65885001
SG	Health Sciences Authority	04683P
TN	Direction de la Pharmacie et du Médicament	6530065H, 9243121, 9243122
US	FDA, National Drug Code	0009-0003, 0009-0018, 0009-0039, 0009-0047, 0009-0698, 0009-0758, 0009-0850, 50090-0271, 51662-1263, 51662-1264, 51662-1483, 52584-039, 52584-047, 55154-3939, 55154-3940, 55154-3941, 55154-3944, 68071-1792, 70518-2023, 71872-7061
ZA	Health Products Regulatory Authority	D/21.5.1/136, D/21.5.1/35, L/21.5.1/25, L/21.5.1/26